BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31098814)

  • 1. Cholesterol Binding Sites in Inwardly Rectifying Potassium Channels.
    Rosenhouse-Dantsker A
    Adv Exp Med Biol; 2019; 1135():119-138. PubMed ID: 31098814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Crosstalk to Synergism: The Combined Effect of Cholesterol and PI(4,5)P
    Bukiya AN; Rosenhouse-Dantsker A
    Adv Exp Med Biol; 2023; 1422():169-191. PubMed ID: 36988881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of cholesterol sensitivity of Kir channels: role of the CD loop.
    Rosenhouse-Dantsker A; Leal-Pinto E; Logothetis DE; Levitan I
    Channels (Austin); 2010; 4(1):63-6. PubMed ID: 19923917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP
    Ha J; Xu Y; Kawano T; Hendon T; Baki L; Garai S; Papapetropoulos A; Thakur GA; Plant LD; Logothetis DE
    J Biol Chem; 2018 Mar; 293(10):3546-3561. PubMed ID: 29317494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inwardly rectifying potassium channels: their structure, function, and physiological roles.
    Hibino H; Inanobe A; Furutani K; Murakami S; Findlay I; Kurachi Y
    Physiol Rev; 2010 Jan; 90(1):291-366. PubMed ID: 20086079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal inwardly rectifying K(+) channels differentially couple to PDZ proteins of the PSD-95/SAP90 family.
    Nehring RB; Wischmeyer E; Döring F; Veh RW; Sheng M; Karschin A
    J Neurosci; 2000 Jan; 20(1):156-62. PubMed ID: 10627592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distant cytosolic residues mediate a two-way molecular switch that controls the modulation of inwardly rectifying potassium (Kir) channels by cholesterol and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)).
    Rosenhouse-Dantsker A; Noskov S; Han H; Adney SK; Tang QY; Rodríguez-Menchaca AA; Kowalsky GB; Petrou VI; Osborn CV; Logothetis DE; Levitan I
    J Biol Chem; 2012 Nov; 287(48):40266-78. PubMed ID: 22995912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-Binding Sites in GIRK Channels: The Devil is in the Details.
    Rosenhouse-Dantsker A
    Lipid Insights; 2018; 11():1178635317754071. PubMed ID: 29467578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus.
    Bukiya AN; Durdagi S; Noskov S; Rosenhouse-Dantsker A
    J Biol Chem; 2017 Apr; 292(15):6135-6147. PubMed ID: 28213520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.
    Pegan S; Arrabit C; Zhou W; Kwiatkowski W; Collins A; Slesinger PA; Choe S
    Nat Neurosci; 2005 Mar; 8(3):279-87. PubMed ID: 15723059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural diversity in the cytoplasmic region of G protein-gated inward rectifier K+ channels.
    Inanobe A; Matsuura T; Nakagawa A; Kurachi Y
    Channels (Austin); 2007; 1(1):39-45. PubMed ID: 19151589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel cholesterol-binding regions in Kir2 channels.
    Rosenhouse-Dantsker A; Noskov S; Durdagi S; Logothetis DE; Levitan I
    J Biol Chem; 2013 Oct; 288(43):31154-64. PubMed ID: 24019518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inwardly rectifying potassium channels: their molecular heterogeneity and function.
    Isomoto S; Kondo C; Kurachi Y
    Jpn J Physiol; 1997 Feb; 47(1):11-39. PubMed ID: 9159640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs.
    Kobayashi T; Washiyama K; Ikeda K
    Neuropsychopharmacology; 2004 Oct; 29(10):1841-51. PubMed ID: 15150531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil.
    Kobayashi T; Washiyama K; Ikeda K
    Neuropsychopharmacology; 2006 Mar; 31(3):516-24. PubMed ID: 16123769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activation of G protein-gated inwardly rectifying potassium channels by cholesterol and PI(4,5)P
    Bukiya AN; Rosenhouse-Dantsker A
    Biochim Biophys Acta Biomembr; 2017 Jul; 1859(7):1233-1241. PubMed ID: 28377218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular switch controls the impact of cholesterol on a Kir channel.
    Corradi V; Bukiya AN; Miranda WE; Cui M; Plant LD; Logothetis DE; Tieleman DP; Noskov SY; Rosenhouse-Dantsker A
    Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2109431119. PubMed ID: 35333652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral Specificity of Cholesterol Orientation Within Cholesterol Binding Sites in Inwardly Rectifying K
    Barbera N; Levitan I
    Adv Exp Med Biol; 2019; 1115():77-95. PubMed ID: 30649756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct specificities of inwardly rectifying K(+) channels for phosphoinositides.
    Rohács T; Chen J; Prestwich GD; Logothetis DE
    J Biol Chem; 1999 Dec; 274(51):36065-72. PubMed ID: 10593888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).
    Kobayashi T; Washiyama K; Ikeda K
    Br J Pharmacol; 2003 Mar; 138(6):1119-28. PubMed ID: 12684268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.